Myungmoon Linagliptin Duo Tablet 2.5/850mg

Adult dose

The dosage of this medication should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of linagliptin 2.5 mg and metformin 1000 mg taken twice a day. This medication is administered twice daily with meals. 1. If currently not undergoing metformin treatment: The initial dose is 2.5/500 mg of this medication taken twice daily, one tablet at a time.

This medication consists of two components, metformin and linagliptin, and is primarily used for blood sugar control in patients with type 2 diabetes. This medication should not be administered to certain patients, such as those allergic to its ingredients, type 1 diabetes patients, individuals with severe renal impairment, patients with acute cardiac conditions or heart failure, patients with severe hepatic impairment, and women who are pregnant or breastfeeding. When taking this medication, there is a risk of hypoglycemia, especially if taken with sulfonylureas or insulin, so it is important to monitor blood sugar levels closely. The metformin ingredient can cause a rare but serious side effect known as lactic acidosis, so in situations that may lead to dehydration, severe infections, or renal function decline, the use of this medication should be discontinued immediately, and medical consultation should be sought. As this medication is excreted through the kidneys, regular kidney function tests are necessary, and dosage adjustment or discontinuation may be needed if renal function declines. Additionally, rare side effects such as acute pancreatitis or vesicular skin conditions have been reported, so if persistent abdominal pain or skin abnormalities appear, prompt consultation with a physician is advisable. This medication can interact with other drugs, so if you are taking other medications, you must inform your healthcare provider, particularly when combined with medications that may affect renal function. It is recommended that pregnant women or those planning to become pregnant, as well as breastfeeding women, do not use this medication and should consult alternative treatment options for blood sugar control. Elderly individuals are at higher risk for declining renal function, so regular renal function tests are required, and dosage adjustments should be made as necessary. During the course of taking this medication, caution is advised when driving or operating machinery, depending on symptoms. In the case of overdose, there is a risk of gastrointestinal disturbances and lactic acidosis, so it is imperative to visit a medical institution immediately for appropriate treatment. This medication should be kept out of reach of children and stored away from moisture and direct sunlight.

Serious side effects

• Urticaria
• angioedema
• lactic acidosis
• pancreatitis
• similar erythema multiforme
• abnormal liver function tests
• hepatitis
• severe and disabling joint pain
• acute kidney injury
• acute cholangitis

Mild side effects

• Hypersensitivity
• nasopharyngitis
• cough
• decreased appetite
• diarrhea
• constipation
• nausea
• vomiting
• abdominal pain
• oral ulcer formation

This medication is sensitive to air and moisture; therefore, it must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance

Bright orange, round, biconvex, film-coated tablet

Package unit

60 tablets (10 tablets/PTPX6)